Inventor profile of:

Lon T. Spada

City:

Walnut, California

Country:

United States

Published Applications:

64

Last publication date:

2025-02-13

Top Assignees for applications by Lon T. Spada

The entities that hold a legal rights for patent applications filed by inventor Spada Lon T.:

Recent patent applications by Spada Lon T.

Lon T. Spada from Walnut, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-13
US20250049994A1
Human necessities

POLYMER SYSTEM FOR SECURING IMPLANTS IN SYRINGE NEEDLES

#2 | 2024-10-31
US20240358641A1
Human necessities

PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE

#3 | 2023-09-14
US20230285279A1
Human necessities

BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF

#4 | 2022-01-13
US20220008628A1
Human necessities

POLYMER SYSTEM FOR SECURING IMPLANTS IN SYRINGE NEEDLES

#5 | 2021-10-21
US20210322318A1
Human necessities

PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE

#6 | 2021-06-03
US20210161809A1
Human necessities

BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF

#7 | 2021-04-29
US20210121397A1
Human necessities

BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS

#8 | 2020-03-05
US20200069578A1
Human necessities

Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof

#9 | 2020-02-06
US20200038326A1
Human necessities

PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE

#10 | 2019-02-07
US20190038551A1
Human necessities

Biodegradable intravitreal tyrosine kinase implants

#11 | 2018-12-13
US20180353426A1
Human necessities

Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof

#12 | 2017-04-13
US20170100334A1
Human necessities

Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof

#13 | 2016-08-25
US20160243032A1
Human necessities

STEROID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS

#14 | 2016-07-14
US20160199297A1
Human necessities

Biodegradable intravitreal tyrosine kinase implants

#15 | 2016-02-04
US20160030334A1
Human necessities

Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof

#16 | 2016-01-28
US20160022581A1
Human necessities

Processes for making cyclic lipid implants for intraocular use

#17 | 2015-09-24
US20150265633A1
Human necessities

STEROID CONTAINING DRUG DELIVERY SYSTEM

#18 | 2015-05-21
US20150141348A1
Human necessities

Sustained release siRNA for ocular drug delivery

#19 | 2015-03-26
US20150087696A1
Human necessities

METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS

#20 | 2015-03-19
US20150080845A1
Human necessities

POLYMER SYSTEM FOR SECURING IMPLANTS IN SYRINGE NEEDLES

#21 | 2014-12-11
US20140364494A1
Human necessities

Processes for making cyclic lipid implants for intraocular use

#22 | 2014-11-20
US20140341968A1
Human necessities

Intraocular Drug Delivery Systems

#23 | 2014-10-30
US20140322295A1
Human necessities

Steroid-containing sustained release intraocular implants and related methods

#24 | 2014-10-23
US20140314868A1
Human necessities

Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof

#25 | 2014-07-24
US20140205649A1
Human necessities

Solvent cast film sustained release latanoprost implant

#26 | 2014-02-06
US20140038972A1
Human necessities

ALPHA-2 AGONIST POLYMERIC DRUG DELIVERY SYSTEMS

#27 | 2014-01-30
US20140031408A1
Human necessities

Biodegradable intravitreal tyrosine kinase implants

#28 | 2013-10-10
US20130267497A1
Chemistry; metallurgy

KINASE INHIBITORS

#29 | 2013-01-17
US20130017268A1
Human necessities

Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof

#30 | 2012-11-01
US20120276184A1
Human necessities

Solvent cast film sustained release latanoprost implant

#31 | 2012-09-27
US20120245505A1
Human necessities

INTRACAMERAL DEVICES FOR SUSTAINED DELIVERY

#32 | 2012-09-20
US20120238558A9
Chemistry; metallurgy

Kinase inhibitors

#33 | 2012-08-16
US20120207810A1
Chemistry; metallurgy

Kinase Inhibitors

#34 | 2012-05-17
US20120122821A1
Human necessities

Methods of treating ocular disease using steroid-containing sustained release intraocular implants

#35 | 2012-01-26
US20120022137A1
Human necessities

METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS

#36 | 2012-01-26
US20120022002A1
Human necessities

Sustained release siRNA for ocular drug delivery

#37 | 2011-10-27
US20110263611A1
Chemistry; metallurgy

Kinase inhibitors

#38 | 2011-03-31
US20110077229A1
Human necessities

Steroid Containing Drug Delivery Systems

#39 | 2010-09-30
US20100247606A1
Human necessities

INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING OCULAR CONDITIONS

#40 | 2010-05-20
US20100124565A1
Human necessities

Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof

#41 | 2010-04-29
US20100104654A1
Human necessities

PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF

#42 | 2009-11-19
US20090286773A1
Chemistry; metallurgy

Kinase inhibitors

#43 | 2009-08-20
US20090208557A1
Human necessities

Kinase inhibitors

#44 | 2009-08-06
US20090196906A1
Chemistry; metallurgy

Kinase inhibitors

#45 | 2009-08-06
US20090196905A1
Human necessities

STABILIZATION OF MITOCHONDRIAL MEMBRANES IN OCULAR DISEASES AND CONDITIONS

#46 | 2009-03-26
US20090082321A1
Human necessities

STEROID CONTAINING DRUG DELIVERY SYSTEMS

#47 | 2008-08-14
US20080193503A1
Human necessities

MEMANTINE INTRAVITREAL IMPLANTS

#48 | 2008-08-14
US20080193502A1
Human necessities

MEMANTINE INTRAVITREAL IMPLANTS

#49 | 2008-06-19
US20080145407A1
Human necessities

METHODS FOR REDUCING NEOVASCULARIZATION OR EDEMA

#50 | 2008-06-19
US20080145403A1
Human necessities

Low temperature processes for making cyclic lipid implants for intraocular use

#51 | 2008-06-05
US20080131484A1
Human necessities

Intraocular drug delivery systems

#52 | 2007-03-15
US20070059336A1
Human necessities

Anti-angiogenic sustained release intraocular implants and related methods

#53 | 2007-02-08
US20070031472A1
Human necessities

Steroid-containing sustained release intraocular implants and related methods

#54 | 2006-11-02
US20060243696A1
Performing operations; transporting

Tip design for reducing capillary leakage and water loss for plastic container closures

#55 | 2006-10-19
US20060233860A1
Human necessities

Alpha-2 agonist polymeric drug delivery systems

#56 | 2006-08-17
US20060182783A1
Human necessities

Sustained release intraocular drug delivery systems

#57 | 2006-05-25
US20060111680A1
Human necessities

Autoclaveable small-volume dropper bottle

#58 | 2006-02-16
US20060032873A1
Performing operations; transporting

Container system

#59 | 2005-12-22
US20050281861A1
Human necessities

Macromolecule-containing sustained release intraocular implants and related methods

#60 | 2005-12-15
US20050274744A1
Human necessities

Dispensing tip

#61 | 2005-11-03
US20050244475A1
Human necessities

Biodegradable intravitreal tyrosine kinase implants

#62 | 2005-11-03
US20050244474A1
Human necessities

Steroid-containing sustained release intraocular implants and related methods

#63 | 2005-11-03
US20050244473A1
Human necessities

Memantine intravitreal implants

#64 | 2005-09-29
US20050211734A1
Performing operations; transporting

Skirted closure for small dropper bottles

InventorID:

40430 ⎘